Cannabis News
The Scrooge of Cannabis Takes on VP Harris with Reefer Madness
Published
7 months agoon
By
admin
Reginald vs The Scourge – Analyzing Sabet’s latest Reefer Madness
As an advocate for personal responsibility, bodily autonomy and freedom, I have made it my mission to challenge the stance of prohibition and counteract the misinformation that fuels it. The right of individuals to make informed choices about what they put into their own bodies is fundamental. Yet there are still vocal prohibition advocates who spread falsehoods and rely on fearmongering rather than facts. It’s crucial that we critically examine their claims to determine if there is any real scientific and logical basis behind them.
For years, one of the loudest voices on the prohibition side has been Kevin Sabet and his organization SAM (Smart Approaches to Marijuana). Sabet recently co-authored an opinion piece in The Hill arguing against rescheduling cannabis and painting a dire picture of the supposed harms of legalization. But do his arguments hold up to scrutiny?
In this article, we’re going to take a close look at the claims made in Sabet’s latest letter, titled “Kamala Harris is gravely wrong about rescheduling marijuana.” We’ll see if there is factual merit behind the rhetoric, or if it’s simply drug war propaganda fueled by ideology and vested interests.
To be clear, I hold no love for Vice President Harris given her history as a prosecutor who gleefully sent cannabis users to jail as California Attorney General. It pains me to have to defend her recent comments in favor of rescheduling. But intellectual honesty demands calling out Sabet’s flawed arguments, even if Harris and I are strange bedfellows on this issue.
With over 90% of Americans now in favor of legal access to cannabis, at least for medical use, Sabet’s prohibitionist views represent an increasingly marginalized fringe. Yet he still garners attention as the media’s go-to “anti-pot” voice. So join me as we dissect his latest screed and I make the case for why his Reefer Madness mindset belongs in the dustbin of history.
As always, I approach this not as a blind defender of cannabis, but as someone who believes policy should be grounded in science, reason and human rights. Let’s see if Sabet’s arguments meet that bar.
In order to save you all time from reading the Letter, I have gone through some of their arguments and come up with a response to each point. Mainly, I challenge their logic, their conclusion, and whether or not they have a bias in a particular arena.
Let’s go!
“First, we should address what Harris left unsaid. Since his election, Biden has demonstrated that criminal justice reform is possible without commercializing today’s industrialized, high-potency THC drugs or legalizing dangerous psychoactive drugs.”
While President Biden has taken some symbolic steps towards cannabis reform, such as pardoning low-level federal possession offenses, his overall impact on the legal status of cannabis has been sorely lacking. The glaring elephant in the room is that cannabis remains a Schedule I substance under federal law, a classification reserved for drugs with “no currently accepted medical use and a high potential for abuse.”
This scheduling is not only scientifically baseless, but a cruel joke to the millions of patients who rely on cannabis as a safer, less addictive alternative to prescription opioids and other pharmaceuticals for treating conditions like chronic pain, PTSD, epilepsy, and the side effects of chemotherapy. The medical applications of cannabis are extensively documented, with FDA-approved cannabinoid medications like Epidiolex and Marinol just the tip of the iceberg.
Moreover, the notion that cannabis belongs in the same category as heroin in terms of abuse potential is laughable when compared to the legal and widely available drug alcohol, which is far more toxic and addictive by any objective measure. The continued Schedule I status of cannabis is a relic of the racially and politically motivated War on Drugs, not a reflection of scientific reality.
While incremental criminal justice reforms are welcome, they don’t address the root problem of cannabis’ egregious misclassification, which perpetuates stigma, stifles research, and keeps the industry in a legal gray area. If the Biden administration is serious about righting the wrongs of the drug war and embracing an evidence-based approach, it must prioritize the descheduling of cannabis altogether.
Sadly, these glaring contradictions and the need for substantive change seem to be among the many things left “unsaid” by our political leaders, even as public opinion and state-level legalization increasingly leave federal prohibition behind. It’s time for the Biden administration to match its rhetoric with bold action and consign cannabis prohibition to the dustbin of history where it belongs.
“There was no one representing social justice advocates, scientists and public health experts concerned about the harms of marijuana commercialization. Many of these experts have studied the socioeconomic effects of lax marijuana policies, including the fact that pot shops are often concentrated in and target poorer and non-white communities on purpose, much like menthol cigarettes target Black communities.”
Kevin Sabet and his cohorts at SAM love to posture as champions of social justice, but their actions and affiliations tell a different story. It’s high time we called out their cynical exploitation of marginalized communities as a cover for their true agenda – protecting the profits of the rehab industry that funds them.
Let’s be clear: Sabet’s organization has deep financial ties to the very same rehabilitation clinics that benefit from the court-ordered treatment of cannabis users caught up in the criminal justice system. These are the same clinics that are often in cozy partnership with the state, creating a perverse incentive to keep cannabis criminalized and the treatment beds filled. So when Sabet sheds crocodile tears over the impact of legalization on disadvantaged populations, forgive me if I’m a bit skeptical of his sincerity.
If Sabet and friends truly cared about social justice, they’d be working to dismantle the racist and classist drug war policies that have devastated communities of color, not fighting to preserve them. They’d be advocating for restorative justice, expungement of past convictions, and equitable access to the legal cannabis industry, not scaremongering about the supposed harms of legalization.
I’m all for an honest, evidence-based discussion about the public health implications of cannabis policy. Sabet claims to have science on his side? Great – let’s see him square off against the countless medical professionals and researchers who have attested to the therapeutic potential and relative safety of cannabis compared to legal substances like alcohol and tobacco. I’ll bring my experts, he can bring his, and we’ll see whose arguments hold up to scrutiny.
Of course, no policy is without trade-offs and the transition to a legal, regulated cannabis market is no exception. There will undoubtedly be some unforeseen consequences and challenges along the way. But when we weigh the evidence objectively, it’s clear that the overall societal benefits of ending prohibition – from reducing incarceration to generating tax revenue to weakening the illicit market – far outweigh the potential downsides.
So spare me the social justice smokescreen, Kevin. It’s time to have an honest conversation about cannabis policy, one grounded in science, compassion, and a genuine commitment to righting the wrongs of the failed war on drugs. The American people are ready for change – the question is, are you?
“While Biden should be praised for his stance opposing legalization and supporting expungement and removing penalties, rescheduling marijuana would be an abandonment of his efforts to keep drugs off our streets”
Your claim that rescheduling cannabis would undermine efforts to “keep drugs off our streets” would be laughable if the consequences of this thinking weren’t so tragic. News flash: after decades of prohibition and trillions of dollars wasted on enforcement, drugs are more readily available than ever. If you don’t believe me, just ask any high schooler how long it would take them to score some molly or a vape pen. Spoiler alert: probably less time than it takes to get a pizza delivered.
The painful reality is that the War on Drugs has been an abject failure by every conceivable metric. Despite the tireless efforts of the DEA and other law enforcement agencies, the illicit drug trade continues to thrive, with devastating consequences for public health and safety. Overdose deaths are at record highs, cartels are raking in billions, and marginalized communities bear the brunt of the violence and incarceration that prohibition fuels.
It’s time to face the facts, Kevin. We can’t arrest and incarcerate our way out of this crisis. The only way to truly get drugs under control is to bring them out of the shadows and into a system of strict regulation and oversight. By legalizing and regulating substances like cannabis, we can ensure that adults have access to safe, lab-tested products while keeping them out of the hands of minors. We can redirect law enforcement resources toward more serious crimes, and use the tax revenue generated by legal sales to fund education, prevention, and treatment programs.
This isn’t some radical, untested idea – it’s the approach that’s already working in countries like Portugal, where decriminalization has led to dramatic reductions in overdose deaths, HIV transmission rates, and drug-related crime. It’s the direction that more and more U.S. states are moving in with cannabis, as they recognize the failure of prohibition and the benefits of regulation.
Don’t just take my word for it. Let’s look at the data from states that have already legalized cannabis. Teen use has remained stable or even declined, opioid prescriptions and overdoses have fallen, and billions in tax revenue have been generated for public services. The sky hasn’t fallen, Kevin – in fact, by most measures, the situation has improved.
So please, spare us the fear-mongering about legal cannabis flooding the streets with drugs. The streets are already flooded, and it’s prohibition that’s keeping the cartels in business. It’s time for a new approach, one grounded in harm reduction, public health, and respect for individual liberty. The mission of the drug war has failed – it’s time to evolve. The question is, Kevin, are you ready to join us in the 21st century, or will you keep clinging to the failed policies of the past?
“Drug scheduling is not a harm index. It is a legal term that categorizes drugs based on medical benefit and potential for abuse. From a scientific basis, marijuana fails to meet the statutory requirements for any schedule other than Schedule I.”
Kevin, your claim that cannabis meets the criteria for Schedule I would be almost impressive in its sheer audacity if it weren’t so easily debunked by even a cursory glance at the scientific literature and real-world evidence.
Let’s start with the FDA-approved cannabinoid medications Epidiolex and Marinol, which are prescribed for conditions like epilepsy and chemotherapy-induced nausea. How exactly do these fit into your narrative that cannabis has “no currently accepted medical use”? Are you suggesting that the FDA is in on some vast stoner conspiracy?
And that’s just the tip of the iceberg when it comes to the medical applications of cannabis. Countless studies have documented its efficacy in treating chronic pain, muscle spasms, anxiety, PTSD, and a host of other conditions. In states with medical cannabis programs, patients are using it as a safer alternative to prescription opioids, with many able to reduce or eliminate their use of these highly addictive and potentially deadly drugs.
But hey, don’t take my word for it – just ask the millions of people worldwide who have found relief and improved quality of life through medical cannabis. Or consult the numerous medical organizations, like the American Nurses Association and the American Public Health Association, that have endorsed rescheduling or descheduling cannabis to facilitate research and patient access.
The notion that there is no evidence for cannabis’ medical utility is not just factually incorrect – it’s a slap in the face to the patients and healthcare professionals who have seen its benefits firsthand. It’s an ideologically driven talking point that has no place in a serious discussion about science and public health.
So please, Kevin, spare us the Schedule I nonsense. It’s a relic of the racist and politically motivated war on drugs, not a reflection of scientific reality. If you’re going to engage in this debate, at least have the intellectual honesty to grapple with the evidence instead of regurgitating long-debunked prohibitionist myths.
“It is also more dangerous than people think. In fact, the drug has undergone a transformation in its addictive potential. Today’s marijuana is nothing like Woodstock-era weed.”
Oh boy, here we go again with the “today’s pot is not your grandpa’s woodstock weed” scaremongering. Kevin, I hate to break it to you, but this tired talking point is the definition of reefer madness 2.0.
Yes, cannabis potency has increased over the years, thanks in large part to prohibition driving cultivation underground and incentivizing the production of more concentrated products. But the idea that higher THC content automatically equates to increased danger is overly simplistic and ignores the way cannabis is actually consumed in the real world.
The average THC content of popular strains in legal markets hovers around 14% – undoubtedly stronger than the schwag of yesteryear, but a far cry from the 90%+ concentrates that prohibitionists love to wave around to scare soccer moms. And let’s be real, even the most potent bud isn’t going to turn someone into a homicidal maniac. That’s the kind of hysterical nonsense that even the most die-hard D.A.R.E. graduates have trouble believing these days.
What Sabet and his ilk fail to grasp is that cannabis consumers are not mindless slaves to ever-increasing THC levels. People titrate their dose and use a variety of consumption methods to achieve their desired effect, whether that’s relief from pain and anxiety or a social buzz. Regular consumers also develop tolerance over time, meaning that what might be an uncomfortably intense experience for a newbie is just another Tuesday for a seasoned smoker.
Now, this is not to say that cannabis is harmless or that there aren’t risks associated with excessive use, particularly for young people with developing brains. Some folks will undoubtedly develop problematic relationships with cannabis, just as they do with alcohol, gambling, and Fortnite.
But the solution to mitigating those risks is not prohibition and criminalization – we already know how well that works out. It’s legalization, regulation, education, and harm reduction. By bringing cannabis out of the shadows and into a system of age restrictions, potency limits, and mandatory labeling, we can create guardrails to encourage responsible use while respecting the liberty and agency of adults to make their own choices.
And spare me the false equivalence between cannabis and alcohol, Kevin. If you’re going to play the Schedule I card, let’s at least be consistent. By any objective measure, alcohol is far more dangerous and addictive than cannabis – yet I don’t see you crusading to bring back the 18th Amendment. It’s almost as if your selective outrage and disdain for “psychoactive drugs” only applies to the ones you personally disapprove of. Funny how that works, isn’t it?
But hey, I get it. Admitting that you’ve hitched your wagon to a losing battle must be a bitter pill to swallow. But the American people are waking up to the absurdity of cannabis prohibition, and no amount of reefer madness redux is going to put that genie back in the bottle. It’s time to get with the times, Kevin. The future is green whether you like it or not.
SOURCE:
https://thehill.com/opinion/criminal-justice/4559148-kamala-harris
-is-gravely-wrong-about-rescheduling-marijuana/
https://www.marijuanamoment.net/house-gop-committee-urges-opposition-to-marijuana
-banking-bill-saying-gateway-drug-causes-violence-depression-and-suicide/
https://www.marijuanamoment.net/only-one-out-of-ten-americans-wants-to-
keep-marijuana-totally-illegal-pew-poll-shows/
https://www.pewresearch.org/politics/2024/03/26/most-americans-favor-legalizing
-marijuana-for-medical-recreational-use/
MORE ON KEVIN SABET AND SAM, READ ON…
KEVIN SABET IS GOING DOWN ON THE SINKING SHIP OF WEED PROHIBITION
You may like
-
Latest Trump Weed Rumor – Trump Will Federally Deschedule and Decriminalize Cannabis, but Not Legalize It
-
Webinar Replay: Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em
-
I Had Just One Puff
-
Marijuana firms Eaze, Green Dragon find new life after $10 million capital infusion
-
Get some rest on Modified Grapes—November’s Leafly HighLight
-
Is Kratom Addictive? Understanding Dependence, Risks, and Safe Usage
Cannabis News
Latest Trump Weed Rumor – Trump Will Federally Deschedule and Decriminalize Cannabis, but Not Legalize It
Published
6 hours agoon
November 14, 2024By
admin
In a recent interview, former New Jersey Governor Chris Christie made headlines by asserting that President-elect Donald Trump will pursue significant reforms in federal policies regarding marijuana and cryptocurrency. As the nation grapples with evolving attitudes toward cannabis and the burgeoning digital currency market, Christie’s predictions have ignited discussions about the potential implications of such changes on both industries. This article delves into Christie’s insights, the current state of marijuana and cryptocurrency regulations, and the broader implications of these anticipated reforms.
The Current Landscape of Marijuana Legislation
Federal vs. State Laws
Marijuana remains classified as a Schedule I substance under the Controlled Substances Act (CSA), which places it in the same category as heroin and LSD. This classification has created a complex legal landscape where states have moved to legalize cannabis for medical and recreational use, while federal law continues to impose strict prohibitions. As of now, over 30 states have legalized marijuana in some form, leading to a burgeoning industry that generates billions in revenue.
Challenges Faced by the Cannabis Industry
Despite its legality in many states, the cannabis industry faces significant hurdles due to federal restrictions. These challenges include:
-
Banking Access: Many banks are hesitant to work with cannabis businesses due to fear of federal repercussions, forcing these businesses to operate largely in cash.
-
Taxation Issues: The IRS enforces Section 280E of the tax code, which prohibits businesses engaged in illegal activities from deducting normal business expenses, leading to disproportionately high tax burdens for cannabis companies.
-
Interstate Commerce: The lack of federal legalization prevents cannabis businesses from operating across state lines, limiting their growth potential.
Chris Christie’s Perspective on Marijuana Reform
Christie, a former presidential candidate known for his tough stance on drugs during his tenure as governor, has evolved his views on marijuana over the years. In his recent statements, he emphasized that Trump is likely to pursue descheduling cannabis, which would remove it from the Schedule I classification. This move would not only provide clarity for businesses operating in legal markets but also open avenues for banking and investment.
Christie highlighted that descheduling would allow for a more regulated market where safety standards could be established, thus protecting consumers. He believes that this approach aligns with a growing consensus among Americans who support legalization and recognize the potential benefits of cannabis use for both medical and recreational purposes.
The Future of Cryptocurrency Regulation = The Rise of Cryptocurrencies
Cryptocurrencies have surged in popularity over the past decade, with Bitcoin leading the charge as the first decentralized digital currency. The market has expanded to include thousands of alternative coins (altcoins), each with unique features and use cases. As cryptocurrencies gain traction among investors and consumers alike, regulatory scrutiny has intensified.
Current Regulatory Challenges
The cryptocurrency market faces several regulatory challenges that hinder its growth and adoption:
-
Lack of Clarity: Regulatory frameworks vary significantly across states and countries, creating confusion for investors and businesses.
-
Fraud and Scams: The rapid growth of cryptocurrencies has led to an increase in fraudulent schemes targeting unsuspecting investors.
-
Consumer Protection: Without clear regulations, consumers are often left vulnerable to risks associated with volatile markets.
Christie’s Vision for Crypto Regulation
Christie believes that under Trump’s leadership, there will be an effort to find a “sweet spot” for cryptocurrency regulation balancing innovation with consumer protection. He argues that overly stringent regulations could stifle growth in this emerging sector while too little oversight could expose consumers to significant risks.
In his view, a balanced regulatory framework would include:
1. Clear Definitions: Establishing clear definitions for different types of cryptocurrencies and tokens to differentiate between securities and utility tokens.
2. Consumer Protections: Implementing measures to protect investors from fraud while promoting transparency within the market.
3. Encouraging Innovation: Creating an environment conducive to innovation by allowing startups to thrive without excessive regulatory burdens.
Christie’s insights reflect a growing recognition among policymakers that cryptocurrencies are here to stay and that appropriate regulations are necessary to foster growth while safeguarding consumers.
Implications of Proposed Reforms
Economic Impact
The potential reforms proposed by Christie could have far-reaching economic implications:
-
Job Creation: Legalizing marijuana at the federal level could lead to significant job creation within the cannabis industry—from cultivation and production to retail sales.
-
Investment Opportunities: Descheduling cannabis would open up investment opportunities for institutional investors who have been hesitant due to federal restrictions.
-
Boosting Local Economies: Legal cannabis markets have proven beneficial for local economies through increased tax revenues and job creation.
Similarly, clear regulations around cryptocurrencies could stimulate investment in blockchain technology and related industries, fostering innovation and economic growth.
Social Justice Considerations
Both marijuana legalization and sensible cryptocurrency regulations have social justice implications:
-
Addressing Past Injustices: Legalizing marijuana could help rectify past injustices related to drug enforcement policies that disproportionately affected marginalized communities.
-
Financial Inclusion: Cryptocurrencies offer opportunities for financial inclusion for those underserved by traditional banking systems, particularly in low-income communities.
Political Landscape
The political landscape surrounding these issues is complex. While there is bipartisan support for marijuana reform among certain lawmakers, challenges remain in overcoming entrenched opposition. Similarly, cryptocurrency regulation has garnered attention from both sides of the aisle but requires collaboration to establish effective frameworks.
Conclusion
Chris Christie’s predictions about President-elect Donald Trump’s approach to federal marijuana descheduling and cryptocurrency regulation suggest a potential shift in U.S. policy that could significantly reshape both industries. As public opinion evolves on these issues, lawmakers have an opportunity to enact meaningful reforms that promote economic growth while ensuring consumer protection. The anticipated changes could foster a more robust cannabis industry that contributes positively to the economy and addresses social justice concerns, while clear regulatory frameworks for cryptocurrencies could encourage innovation and protect consumers in the digital economy. Stakeholders in both sectors are closely watching these developments, eager to see how potential reforms might impact their futures. While the realization of Christie’s predictions remains uncertain, it’s clear that the conversation around marijuana and cryptocurrency regulation is ongoing and far from settled.
TRUMP 2.0 ON CANNABIS REFORM, READ ON…
TRUMP 2.0 ON FEDERAL CANNABIS REFORM – WHAT DO WE KNOW?
Cannabis News
Webinar Replay: Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em
Published
1 day agoon
November 13, 2024By
admin
On Thursday, November 7th, Vince Sliwoski, Aaron Pelley and Fred Rocafort held a post election discussion “Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em”. Watch the replay!
Key Takeaways from the “Smoke ’em if You’ve Got ’em – 2024 Post Election Cannabis Wrap” Webinar:
- Panelists:
- Vince Sliwoski: Oregon Business lawyer specializing in cannabis and commercial real estate.
- Aaron Pelley: Experienced in cannabis law since Washington’s legalization in 2012.
- Fred Rocafort: Trademark attorney working closely with the cannabis team.
- Election Results Overview:
- Most 2024 cannabis ballot measures did not pass.
- Florida, South Dakota, and North Dakota saw failures.
- Nebraska became the 39th state to legalize cannabis for medical use when it passed two cannabis initiatives, Initiatives 437 and 438.
- Federal and State-Level Developments:
- Medical use is currently legal in 38 states, and 24 states allow recreational use.
- Republican support for marijuana legalization is growing.
- Federal Policy Implications:
- Schedule III Rescheduling: The process to move cannabis to Schedule III is ongoing, which could significantly impact the industry.
- Importance of Federal Appointments: The future of cannabis policy depends heavily on who is appointed to key positions in the administration.
- International and Domestic Trade:
- Schedule III status could ease import/export restrictions on cannabis.
- Unified control of House, Senate, and presidency might expedite legislative progress.
- Economic and Industry Impact:
- Cannabis stocks experienced volatility post-election, reflecting investor uncertainty.
- Federal legalization and banking reforms are crucial for industry stability and growth.
- Future Outlook:
- The potential for federal rescheduling remains strong, with hearings scheduled for early 2025.
- State-level initiatives and regulatory developments will continue to shape the industry.
“How Long Does One Puff of Weed Stay in Your System?”… This topic can be difficult to answer since it is dependent on elements such as the size of the hit and what constitutes a “one hit.” If you take a large bong pull then cough, it might linger in your system for 5-7 days. A moderate dose from a joint can last 3-5 days, whereas a few hits from a vaporizer may last 1-3 days.
The length of time that marijuana stays in the body varies based on a number of factors, including metabolism, THC levels, frequency of use, and hydration.
Delta-9-tetrahydrocannabinol, or THC, is the primary psychoactive component of cannabis. THC and its metabolites, which remain in your body long after the effects have subsided, are detected by drug tests.
Since these metabolites are fat-soluble, they cling to bodily fat molecules. They could thus take a while to fully pass through your system, particularly if your body fat percentage is higher.
THC is absorbed by tissues and organs (including the brain, heart, and fat) and converted by the liver into chemicals such as 11-hydroxy-THC and carboxy-THC. Cannabis is eliminated in feces at a rate of around 65%, while urine accounts for 20%. The leftover amount might be kept within the body.
THC deposited in bodily tissues ultimately re-enters the circulation and is processed by the liver. For frequent users, THC accumulates in fatty tissues quicker than it can be removed, thus it may be detectable in drug tests for days or weeks following consumption.
The detection time varies according to the amount and frequency of cannabis usage. Higher dosages and regular usage result in longer detection times.
The type of drug test also affects detection windows. Blood and saliva tests typically detect cannabis metabolites for shorter periods, while urine and hair samples can reveal use for weeks or even months. In some cases, hair tests have detected cannabis use over 90 days after consumption.
Detection Windows for Various Cannabis Drug Tests
Urine Tests
Among all drug tests, urine testing is the most commonly used method for screening for drug use in an individual.
Detection times vary, but a 2017 review suggests the following windows for cannabis in urine after last use:
– Single-use (e.g., one joint): up to 3 days
– Moderate use (around 4 times a week): 5–7 days
– Chronic use (daily): 10–15 days
– Chronic heavy use (multiple times daily): over 30 days
Blood Tests
Blood tests generally detect recent cannabis use, typically within 2–12 hours after consumption. However, in cases of heavy use, cannabis has been detected up to 30 days later. Chronic heavy use can extend the detection period in the bloodstream.
Saliva Tests
THC can enter saliva through secondhand cannabis smoke, but THC metabolites are only present if you’ve personally smoked or ingested cannabis.
Saliva testing has a short detection window and can sometimes identify cannabis use on the same day. A 2020 review found that THC was detectable in the saliva of frequent users for up to 72 hours after use, and it may remain in saliva longer than in blood following recent use.
In areas where cannabis is illegal, saliva testing is often used for roadside screenings.
Hair Tests
Hair follicle tests can detect cannabis use for up to 90 days. After use, cannabinoids reach the hair follicles through small blood vessels and from sebum and sweat surrounding the hair.
Hair grows at approximately 0.5 inches per month, so a 1.5-inch segment of hair close to the scalp can reveal cannabis use over the past three months.
Factors Affecting THC and Metabolite Retention
The length of time THC and its metabolites stay in your system depends on various factors. Some, like body mass index (BMI) and metabolic rate, relate to individual body processing, not the drug itself.
Other factors are specific to cannabis use, including:
– Dosage: How much you consume
– Frequency: How often you use cannabis
– Method of consumption: Smoking, dabbing, edibles, or sublingual
– THC potency: Higher potency can extend detection time
Higher doses and more frequent use generally extend THC retention. Cannabis consumed orally may remain in the system slightly longer than smoked cannabis, and stronger cannabis strains, higher in THC, may also stay detectable for a longer period.
How Quickly Do the Effects of Cannabis Set In?
When smoking cannabis, effects appear almost immediately, while ingested cannabis may take 1–3 hours to peak.
The psychoactive component THC produces a “high” with common effects such as:
– Altered senses, including perception of time
– Mood changes
– Difficulty with thinking and problem-solving
– Impaired memory
Other short-term effects can include:
– Anxiety and confusion
– Decreased coordination
– Dry mouth and eyes
– Nausea or lightheadedness
– Trouble focusing
– Increased appetite
– Rapid heart rate
– Restlessness and sleepiness
In rare cases, high doses may lead to hallucinations, delusions, or acute psychosis.
Regular cannabis use may have additional mental and physical effects. While research is ongoing, cannabis use may increase the risk of:
– Cognitive issues like memory loss
– Cardiovascular problems including heart disease and stroke
– Respiratory illnesses such as bronchitis or lung infections
– Mood disorders like depression and anxiety
Cannabis use during pregnancy can negatively impact fetal growth and development.
Duration of Effects
Short-term effects generally taper off within 1–3 hours, but for chronic users, some long-term effects may last days, weeks, or even months. Certain effects may even be permanent.
Bottom Line
The amount of time that cannabis remains in your system following a single use varies greatly depending on individual characteristics such as body fat, metabolism, frequency of use, and mode of intake. Frequent users may maintain traces of THC for weeks, whereas infrequent users may test positive for as little as a few days. Hair tests can disclose usage for up to 90 days, while blood and saliva tests identify more recent use. Urine tests are the most popular and have varying detection durations. The duration that THC and its metabolites are detectable will ultimately depend on a number of factors, including dose, strength, and individual body chemistry.
PEE IN A CUP COMING UP, READ ON..
Latest Trump Weed Rumor – Trump Will Federally Deschedule and Decriminalize Cannabis, but Not Legalize It
Webinar Replay: Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em
I Had Just One Puff
Marijuana firms Eaze, Green Dragon find new life after $10 million capital infusion
Get some rest on Modified Grapes—November’s Leafly HighLight
Is Kratom Addictive? Understanding Dependence, Risks, and Safe Usage
New Rule, December 5: Oregon Cannabis Retailers, Processors and Labor Peace Agreements
The CBD Dog Treat Guide
Trippin’ Golf Balls – Can Magic Mushrooms Help Your Golf Game?
Australian Broadcasting Corp Alleges Military Veterans Have Been Targeted By Medicinal Cannabis Companies Via Social Media & Offered Free “Product”
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing11 months ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse